Esketamine Treatment as Usual (ESK) + Virtual-Reality-based mindfulness intervention for depressive disorder, treatment-resistant

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 20 Feb 2026: Trial registered, NCT07422519

The trials

NCT07422519: Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant Depression

State
Under way
Phase
No phase
People
30 planned
Started
18 Sep 2025
Primary completion
15 Dec 2026
Arms
Experimental Arm: Esketamine Plus Mindfulness (ESK-MIND)
Results
None posted
  1. 18 Sep 2025: Trial started
  2. 20 Feb 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.